Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypertonic Dextrose Prolotherapy in Subdeltoid Bursitis
NCT05918146Phase 4Unknown
- Sponsor
- Taipei Medical University
- Start
- Jun 2023
- Primary completion
- Jun 2024
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dextrose in subdeltoid bursitis (2 arms), sponsored by Taipei Medical University. Primary endpoint: Shoulder Pain and Disability Index at 3 months. Status: unknown.
02
Drugs
dextrose
03
Conditions
subdeltoid bursitis
Beyond the preview
Go deeper on NCT05918146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05918146.